The Blue Box Biomedical Solutions

The Blue Box Biomedical Solutions is a healthtech company founded in 2021 and based in Irvine, California, with additional locations in Barcelona, Spain, and Menlo Park, United States. The company focuses on developing an innovative, AI-powered, non-invasive medical device for breast cancer screening that utilizes urine samples. This device is designed to be pain-free, low-cost, and radiation-free, boasting a sensitivity of approximately 88%, which is significantly higher than traditional mammography, particularly for women aged 20-49. The core product is inspired by a dog's olfactory system and aims to detect breast cancer biomarkers in urine. This technology addresses a critical gap in breast cancer screening for younger women, who often lack reliable options. The Blue Box operates on a Diagnostics-as-a-Service model, planning to launch its product in private gynecology clinics by 2024-2026. The company has collaborated with seven hospitals and conducted clinical studies with over 450 women to validate its technology, with a goal of democratizing access to early breast cancer detection for medically underserved populations.

• Employees 15
• Founded 2021